Mobile

DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF A 4-WEEK TREATMENT WITH ORAL DOSES OF MEN15596 IN IRRITABLE BOWEL SYNDROME

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000214-71

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of three doses of MEN 15596 on IBS symptoms relief as compared to placebo in a broad population of irritable bowel syndrome (IBS) patients following a 4 week oral treatment.

Critère d'inclusion

  • Irritable bowel syndrome

Liens